scholarly article | Q13442814 |
P356 | DOI | 10.1200/JCO.2016.69.4935 |
P8608 | Fatcat ID | release_2a2cmsyajrhhnlo5ratr6qxlmu |
P932 | PMC publication ID | 5501359 |
P698 | PubMed publication ID | 28448241 |
P50 | author | Olufunmilayo Olopade | Q7088836 |
Shirley Hodgson | Q15995134 | ||
Ali Amin Al Olama | Q57565560 | ||
Christi J van Asperen | Q58235238 | ||
Anna Marie Mulligan | Q59659727 | ||
Esther M. John | Q59752419 | ||
Douglas F. Easton | Q59812154 | ||
Miguel de la Hoya | Q60551322 | ||
Diana Eccles | Q61756107 | ||
Kathleen Claes | Q62097128 | ||
Susan M Domchek | Q62515230 | ||
Kenneth Offit | Q20732365 | ||
Rita Schmutzler | Q21264574 | ||
Rosalind Eeles | Q24640445 | ||
Domenico Palli | Q28360650 | ||
Ute Hamann | Q28484017 | ||
Gareth Evans | Q29642643 | ||
Heli Nevanlinna | Q29840669 | ||
Shan Wang-Gohrker | Q30831711 | ||
Edith Olah | Q62560279 | ||
Alfons Meindl | Q63015490 | ||
Fergus J. Couch | Q63018779 | ||
Susan L Neuhausen | Q63019538 | ||
Jeffrey N Weitzel | Q63032640 | ||
Lesley McGuffog | Q63233438 | ||
Leigha Senter | Q63370944 | ||
Barbara Wappenschmidt | Q63444312 | ||
Debra Frost | Q64516041 | ||
Jacques Simard | Q64516110 | ||
Irene L Andrulis | Q64516140 | ||
Valentina Silvestri | Q64821309 | ||
Conxi Lázaro | Q64856423 | ||
Marc Tischkowitz | Q66439010 | ||
Gord Glendon | Q73633107 | ||
Nick Orr | Q78318000 | ||
Julie Lecarpentier | Q80442806 | ||
Giulia Cini | Q85938566 | ||
Marco Montagna | Q87215039 | ||
Torben A Kruse | Q87518225 | ||
Karin Kast | Q87624397 | ||
Jackie Cook | Q87691893 | ||
Lídia Feliubadaló | Q45906974 | ||
Anne-Bine Skytte | Q47502231 | ||
Ian G. Campbell | Q47503141 | ||
Pedro Pinto | Q49097360 | ||
Uffe Birk Jensen | Q50544001 | ||
Mark Robson | Q51026477 | ||
Lone Sunde | Q51628358 | ||
Sara Gutiérrez-Enríquez | Q54476812 | ||
Paolo Radice | Q37372139 | ||
Joan Brunet | Q37378402 | ||
Stefania Tommasi | Q37843386 | ||
Manuel R. Teixeira | Q41584388 | ||
Alex Henderson | Q41685184 | ||
Judith Balmaña | Q41839999 | ||
Julian Weldon Adlard | Q42687656 | ||
kConFab Investigators | Q42807245 | ||
Ana Osorio | Q43181086 | ||
Norbert Arnold | Q43506746 | ||
Amanda Spurdle | Q45904058 | ||
Karoline Kuchenbaecker | Q37076233 | ||
Katherine L Nathanson | Q37369859 | ||
Alessandra Viel | Q55128539 | ||
Sylvie Mazoyer | Q55136930 | ||
Melissa C. Southey | Q55446228 | ||
Ines Zanna | Q56065913 | ||
Maria Adelaide Caligo | Q56065914 | ||
Florentia Fostira | Q56246077 | ||
Christoph Engel | Q56261483 | ||
Mark H Greene | Q56435504 | ||
Adalgeir Arason | Q56436993 | ||
Jacopo Azzollini | Q56524223 | ||
Priyanka Sharma | Q56524225 | ||
Daniel Barrowdale | Q56524229 | ||
Orland Diez | Q56524234 | ||
Sofia Khan | Q56551025 | ||
Bernard Peissel | Q56551029 | ||
Siranoush Manoukian | Q56697298 | ||
Yen Y Tan | Q56855815 | ||
Alex Teulé | Q56855834 | ||
Goska Leslie | Q56855923 | ||
Jesús Del Valle | Q56855924 | ||
Javier Benitez | Q56856067 | ||
Joe Dennis | Q56875626 | ||
Vijai Joseph | Q56875726 | ||
Rosa B Barkardottir | Q114188703 | ||
Sue Kyung Park | Q114329424 | ||
Oskar T H Johannsson | Q114337472 | ||
Yuan Chun Ding | Q114337484 | ||
Rachel C Jankowitz | Q114337490 | ||
Johanna I Kiiski | Q114337491 | ||
Miquel Angel Pujana | Q114337498 | ||
Elisa Alducci | Q114337557 | ||
Laure Barjhoux | Q114337610 | ||
Lucy E Side | Q114337625 | ||
Nina Ditsch | Q114337662 | ||
Rosemarie Davidson | Q114337667 | ||
Kim De Leeneer | Q114337680 | ||
Sook-Yee Yoon | Q114337681 | ||
Silvia Tognazzo | Q114337691 | ||
Christine Lasset | Q114337700 | ||
Pragna Gaddam | Q114337735 | ||
Kai-Ren Ong | Q114337737 | ||
Muriel Belotti | Q114337779 | ||
Anna Sara Navazio | Q114452295 | ||
Virginia Valentini | Q114452300 | ||
Veronica Zelli | Q114452301 | ||
Henriette Roed Nielsen | Q114579195 | ||
Veronica Medici | Q117254050 | ||
Eric Hahnen | Q88011049 | ||
Zisun Kim | Q88109580 | ||
Dieter Niederacher | Q88206719 | ||
Laura Ottini | Q88368619 | ||
Doris Steinemann | Q89074687 | ||
Soo Hwang Teo | Q89171700 | ||
Laura Cortesi | Q89654300 | ||
Timothy R Rebbeck | Q89717690 | ||
Antonis C Antoniou | Q89766295 | ||
Andrew K Godwin | Q89896596 | ||
Trinidad Caldes | Q90579504 | ||
Eunyoung Kang | Q90619959 | ||
Jonathan P Tyrer | Q91084019 | ||
Esther Darder | Q91271701 | ||
Bernd Dworniczak | Q91271704 | ||
Pedro Pérez-Segura | Q91723131 | ||
David Goldgar | Q91793745 | ||
Jihyoun Lee | Q92628849 | ||
Kerstin Rhiem | Q92889178 | ||
Inge Søkilde Pedersen | Q93111381 | ||
Piera Rizzolo | Q95948200 | ||
Louise Izatt | Q95987963 | ||
Penny Soucy | Q98148364 | ||
Carole Brewer | Q98148371 | ||
Andrea Gehrig | Q98148373 | ||
GEMO Study Collaborators | Q98148395 | ||
Francesca Damiola | Q98148424 | ||
Vanesa García-Barberán | Q101050010 | ||
Anders Bryø Bojesen | Q105699099 | ||
Saundra S. Buys | Q109562977 | ||
Tracy-Anne De Silva | Q112736228 | ||
Thomas V O Hansen | Q114122103 | ||
Mads Thomassen | Q114122189 | ||
Bruce Poppe | Q114166160 | ||
Bjarni A Agnarsson | Q114188682 | ||
Anna von Wachenfeldt | Q114188695 | ||
P2093 | author name string | Paul James | |
Andreas Berger | |||
Andrew Lee | |||
Christian F Singer | |||
Christian Sutter | |||
Linda Steele | |||
Lisa Walker | |||
Steve Ellis | |||
Mary E Porteous | |||
Gillian Mitchell | |||
Jennifer T Loud | |||
Jan Hauke | |||
Sung-Won Kim | |||
Jong Won Lee | |||
Min Hyuk Lee | |||
Giuseppe Damante | |||
Dezheng Huo | |||
EMBRACE | |||
HEBON | |||
Lotte Krogh | |||
Sarah M Nielsen | |||
Angel Izquierdo | |||
Angela Toss | |||
Miklos Kasler | |||
Jacob Musinsky | |||
Helene Holland | |||
Mattias Van Heetvelde | |||
Christa Lorenchick | |||
Dorothea Wand | |||
Thomas A Conner | |||
Tibor Vaszko | |||
P2860 | cites work | BRCA1 and BRCA2 mutations in a population-based study of male breast cancer | Q24803673 |
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk | Q27008356 | ||
Multiple newly identified loci associated with prostate cancer susceptibility | Q28268180 | ||
Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study | Q29030107 | ||
Large-scale genotyping identifies 41 new loci associated with breast cancer risk | Q29416989 | ||
Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk | Q29417050 | ||
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study | Q29417074 | ||
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array | Q29417155 | ||
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. | Q46332214 | ||
A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impact | Q37632049 | ||
Male breast cancer: genetics, epigenetics, and ethical aspects. | Q38153187 | ||
Novel and known genetic variants for male breast cancer risk at 8q24.21, 9p21.3, 11q13.3 and 14q24.1: results from a multicenter study in Italy | Q41507618 | ||
Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. | Q43073144 | ||
Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in Italy. | Q44567135 | ||
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. | Q31043651 | ||
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers | Q33614244 | ||
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study | Q33927384 | ||
Genetic variants at chromosomes 2q35, 5p12, 6q25.1, 10q26.13, and 16q12.1 influence the risk of breast cancer in men | Q34031201 | ||
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction | Q34394665 | ||
Cancer risks in BRCA2 mutation carriers | Q34504452 | ||
Cancer Incidence in BRCA1 mutation carriers | Q34527264 | ||
Breast cancer risk among male BRCA1 and BRCA2 mutation carriers | Q34718829 | ||
Polygenic susceptibility to prostate and breast cancer: implications for personalised screening | Q34977428 | ||
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation | Q35064451 | ||
Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk | Q35102646 | ||
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer | Q35248192 | ||
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients | Q35527158 | ||
Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis | Q35602297 | ||
Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans | Q35646703 | ||
Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci | Q35815958 | ||
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. | Q35940158 | ||
Germline BRCA1 mutations increase prostate cancer risk | Q35949522 | ||
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer | Q35957703 | ||
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer | Q35996692 | ||
Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC. | Q36295073 | ||
Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk | Q36720814 | ||
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers | Q36742577 | ||
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer | Q36859142 | ||
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer | Q36897003 | ||
The role of BRCA1 and BRCA2 in prostate cancer | Q37037789 | ||
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. | Q37367871 | ||
P433 | issue | 20 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | BRCA1 Mutation | Q28444960 |
BRCA2 Mutation | Q28444961 | ||
P304 | page(s) | 2240-2250 | |
P577 | publication date | 2017-04-27 | |
P1433 | published in | Journal of Clinical Oncology | Q400292 |
P1476 | title | Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores | |
P478 | volume | 35 |
Q92073801 | A New Era of Prostate Cancer Precision Medicine |
Q92980386 | Association between TP53 gene codon72 polymorphism and prostate cancer risk: A systematic review and meta-analysis |
Q92397956 | BRCA mutation testing for first-degree relatives of women with high-grade serous ovarian cancer |
Q63884154 | BRCA2 and Other DDR Genes in Prostate Cancer |
Q64104423 | BRCAness in prostate cancer |
Q49888054 | Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies. |
Q57907570 | Counseling and Testing for Inherited Predisposition to Cancer |
Q91669790 | Current progress and questions in germline genetics of prostate cancer |
Q92125098 | Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk |
Q64080586 | Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer |
Q47900293 | Genome-wide association studies of cancer: current insights and future perspectives |
Q64236058 | Genomic Predictors of Asthma Phenotypes and Treatment Response |
Q90181459 | Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers |
Q49773206 | Men seeking counselling in a Breast Cancer Risk Evaluation Clinic. |
Q92736191 | Metachronous or synchronous male breast and prostate cancers a duality to lookout for |
Q92784849 | Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression |
Q41667232 | Overexpression of MUC1 and Genomic Alterations in Its Network Associate with Prostate Cancer Progression |
Q98611548 | Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions |
Q64228296 | Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines |
Q93179267 | Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study |
Q47134060 | Prostate Cancer: From Genomics to the Whole Body and Beyond |
Q91746992 | Quantifying the Potential for Future Gene Therapy to Lower Lifetime Risk of Polygenic Late-Onset Diseases |
Q60918179 | Role of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors |
Q88778863 | The personal and clinical utility of polygenic risk scores |
Q101476602 | Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome |
Q90278100 | Why is prostate cancer incidence rising in young men? |
Search more.